ArticleThe British journal of dermatology2015
Risk of depression in women with psoriasis: a cohort study.
Article in The British journal of dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.
- Nano intervention in topical delivery of corticosteroid for psoriasis and atopic dermatitis-a systematic review.Journal of materials science. Materials in medicine · 2021Pooled it
- Systematic review of mental health comorbidities in psoriatic arthritis.Clinical rheumatology · 2020Pooled it
- Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology.Anais brasileiros de dermatologia · 2019Guideline
- Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials.Journal of the European Academy of Dermatology and Venereology : JEADV · 2017Trial
- Article
- Psychopharmacology in Dermatology.Indian dermatology online journal · 2026Article
- The Mind Body Connection in Dermatologic Conditions: A Literature Review.Journal of cutaneous medicine and surgery · 2023Review
- Endometriosis, Psoriasis, and Psoriatic Arthritis: A Prospective Cohort Study.American journal of epidemiology · 2022Article
- First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis.Scientific reports · 2021Article
- Association of Psoriasis With Anxiety and Depression: A Case-Control Study in Chinese Patients.Frontiers in medicine · 2021Article
- Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study.JAMA dermatology · 2020Article
- Big data highlights the association between psoriasis and fibromyalgia: a population-based study.Immunologic research · 2020Article
- Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk.Acta dermato-venereologica · 2020Review
- Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis.Clinical, cosmetic and investigational dermatology · 2020Article
- Interleukine-17 Administration Modulates Adult Hippocampal Neurogenesis and Improves Spatial Learning in Mice.Journal of molecular neuroscience : MN · 2019Article
- Phenotypic changes of lymphocyte populations in psoriasiform dermatitis animal model.Experimental and therapeutic medicine · 2019Article
- Predictive Value of Fissured Tongue in Functional Dyspepsia Combined with Depression.Gastroenterology research and practice · 2019Article
- Bridging the Gaps in the Care of Psoriasis and Psoriatic Arthritis: the Role of Combined Clinics.Current rheumatology reports · 2018Review
- Psoriasis and comorbid diseases: Epidemiology.Journal of the American Academy of Dermatology · 2017Review
- Psoriasis and comorbid diseases: Implications for management.Journal of the American Academy of Dermatology · 2017Review
Corrections and comments
- Commented on by
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundPsoriasis is a common, chronic and inflammatory disease of the skin, which has been associated with depression in cross-sectional studies with limited adjustment for confounders.
objectivesIn this prospective cohort study, we investigated the risk of incident depression among individuals with psoriasis and psoriatic arthritis (PsA).
methodsWe included 50 750 US female nurses from the Nurses' Health Study who were free of depression at baseline in 2000. Those participants who had ever self-reported clinician-diagnosed depression or regular use of antidepressants, or had a Mental Health Inventory score of ≤ 52 were excluded. In 2008, we retrospectively asked participants if they had ever received a physician's diagnosis of psoriasis or PsA. We defined depression as self-report of clinician-diagnosed depression or regular use of antidepressant medication. Time-dependent Cox proportional hazard models were used to estimate age and multivariate-adjusted relative risks (RRs) of clinical depression.
resultsAfter adjusting for covariates including body mass index, physical activity, smoking and the presence of major chronic conditions, the multivariate-adjusted RRs of clinical depression were 1·29 [95% confidence interval (CI) 1·10-1·52] for women with psoriasis and 1·52 (95% CI 1·06-2·19) for women with psoriasis and concomitant PsA, compared with women without psoriasis.
conclusionsWe found an increased risk of depression in US women with psoriasis compared with those without psoriasis. This risk was higher in those who reported concomitant PsA. Future studies are needed to confirm these findings in other populations and to identify pathophysiological mechanisms linking psoriasis to depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.